Withheld: assets, equity, liabilities could not be reconciled with the rest of this filer’s statement.
HYSTER-YALE, INC. (HY) reported revenue of $812.90M and net income of -$31.60M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from HYSTER-YALE, INC.’s SEC filings, each linked to the filing it came from.
Income
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $812.90M | $795.20M | $923.20M | $979.10M | $956.60M | $910.40M | $1.07B | $1.02B | $1.17B | $1.06B |
| Cost of revenue | $685.30M | $670.40M | $792.20M | $823.20M | $788.40M | $732.70M | $859.90M | $823.20M | $908.80M | $820.80M |
| Gross profit | $127.60M | $124.80M | $131.00M | $155.90M | $168.20M | $177.70M | $207.60M | $192.90M | $259.30M | $235.70M |
| Operating income | -$18.40M | -$28.00M | -$37.20M | $2.30M | -$8.50M | $21.30M | $32.30M | $33.10M | $95.60M | $83.80M |
| Net income | -$31.60M | -$30.50M | -$52.50M | -$2.30M | -$13.90M | $8.60M | $10.30M | $17.20M | $63.30M | $51.50M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 17.91M | shares 17.82M | Unavailable | shares 17.72M | shares 17.70M | shares 17.77M | Unavailable | shares 17.75M | shares 17.66M | shares 17.59M |
| Pretax income | -$23.20M | -$32.10M | -$41.90M | -$4.60M | -$13.20M | $16.80M | $24.00M | $28.10M | $90.00M | $76.90M |
| Income tax expense | $8.10M | -$1.80M | $9.70M | -$2.90M | $200.00K | $8.10M | $13.30M | $10.30M | $26.10M | $25.10M |
| Diluted EPS | $-1.76 | $-1.71 | Unavailable | $-0.13 | $-0.79 | $0.48 | Unavailable | $0.97 | $3.58 | $2.93 |
| Selling, general & administrative | $144.30M | $151.20M | $146.70M | $152.60M | $161.00M | $156.20M | $153.90M | $158.60M | $163.70M | $151.90M |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Total assets | $1.93B | $1.96B | $2.02B | $2.06B | $2.08B | $2.06B | $2.03B | $2.17B | $2.12B | $2.12B |
| Current assets | $1.28B | $1.31B | $1.35B | $1.44B | $1.46B | $1.45B | $1.43B | $1.56B | $1.53B | $1.53B |
| Total liabilities | $1.52B | $1.51B | $1.53B | $1.51B | $1.51B | $1.53B | $1.54B | $1.62B | $1.63B | $1.69B |
| Current liabilities | $999.60M | $992.90M | $1.00B | $1.04B | $1.04B | $1.05B | $1.06B | $1.15B | $1.17B | $1.22B |
| Total equity incl. NCI | $393.90M | $434.40M | $476.30M | $540.30M | $548.90M | $514.30M | $479.20M | $534.00M | $467.90M | $414.40M |
| Temporary (mezzanine) equity | $16.10M | $16.50M | $16.10M | $15.10M | $14.50M | $15.10M | $14.90M | Unavailable | $14.20M | $14.90M |
| Inventory | $627.50M | $643.80M | $634.30M | $740.30M | $776.60M | $772.70M | $754.30M | $855.30M | $790.70M | $841.90M |
| Accounts receivable | $484.80M | $471.20M | $489.60M | $520.60M | $512.10M | $506.10M | $488.40M | $542.50M | $578.70M | $520.50M |
| Goodwill | $55.50M | $54.60M | $55.70M | $55.50M | $55.40M | $51.20M | $54.60M | $58.20M | $51.60M | $52.00M |
| Long-term debt | $259.20M | $251.10M | $251.90M | $252.20M | $245.20M | $242.60M | $241.90M | $247.40M | $248.50M | $239.70M |
| Accounts payable | $414.30M | $399.90M | $396.10M | $472.00M | $465.20M | $464.00M | $447.80M | $527.90M | $506.70M | $565.90M |
Cash flow
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $16.70M | -$32.90M | $56.50M | $37.10M | $28.90M | -$36.40M | $80.70M | $70.10M | -$2.50M | $22.40M |
| Capital expenditures | $14.70M | $9.80M | $23.60M | $14.50M | $13.80M | $10.60M | $17.90M | $10.20M | $12.20M | $7.50M |
| Investing cash flow | -$14.20M | -$9.30M | -$22.90M | -$14.20M | -$15.30M | -$10.30M | -$16.90M | -$12.00M | -$11.70M | -$7.00M |
| Financing cash flow | -$11.30M | $1.30M | $17.60M | -$18.10M | -$26.20M | $25.90M | -$37.90M | -$50.80M | $19.10M | -$30.50M |
| Net change in cash | -$9.20M | -$41.40M | $52.10M | $4.20M | -$10.30M | -$19.40M | $21.00M | $9.10M | $4.30M | -$16.60M |
| Stock-based compensation | $1.40M | $4.40M | -$800.00K | $2.10M | $2.70M | $3.50M | $1.70M | $4.50M | $8.20M | $9.20M |
| Common dividends paid | $6.60M | $6.40M | $6.50M | $6.30M | $6.40M | $6.20M | $6.10M | $6.10M | $6.10M | $5.70M |
| Common share repurchases | $0 | $700.00K | -$9.00M | $100.00K | -$100.00K | $4.50M | -$23.10M | $0 | $0 | $9.10M |
| Depreciation & amortization | $10.90M | $11.30M | $11.70M | $11.30M | $11.80M | $11.00M | $11.80M | $11.70M | $12.40M | $11.70M |
Derived
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $2.00M | -$42.70M | $32.90M | $22.60M | $15.10M | -$47.00M | $62.80M | $59.90M | -$14.70M | $14.90M |
| Gross margin | 15.7% | 15.7% | 14.2% | 15.9% | 17.6% | 19.5% | 19.4% | 19.0% | 22.2% | 22.3% |
| Operating margin | -2.3% | -3.5% | -4.0% | 0.2% | -0.9% | 2.3% | 3.0% | 3.3% | 8.2% | 7.9% |
| FCF margin | 0.2% | -5.4% | 3.6% | 2.3% | 1.6% | -5.2% | 5.9% | 5.9% | -1.3% | 1.4% |
| SBC / revenue | 0.2% | 0.6% | -0.1% | 0.2% | 0.3% | 0.4% | 0.2% | 0.4% | 0.7% | 0.9% |
| Current ratio | 1.28x | 1.31x | 1.34x | 1.39x | 1.40x | 1.38x | 1.35x | 1.36x | 1.31x | 1.25x |
| Revenue YoY growth | -15.0% | -12.7% | -13.5% | -3.6% | -18.1% | -13.8% | 3.9% | 1.5% | 7.1% | Unavailable |
| Net margin | -3.9% | -3.8% | -5.7% | -0.2% | -1.5% | 0.9% | 1.0% | 1.7% | 5.4% | 4.9% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 1.8% | 1.2% | 2.6% | 1.5% | 1.4% | 1.2% | 1.7% | 1.0% | 1.0% | 0.7% |
| Long-term debt / equity | 0.66x | 0.58x | 0.53x | 0.47x | 0.45x | 0.47x | 0.50x | 0.46x | 0.53x | 0.58x |
| Effective tax rate | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | 48.2% | 55.4% | 36.7% | 29.0% | 32.6% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open HY in the interactive workspace to inspect any figure back to its filing.
Source filings
Companies in the same industry
Reconciliation checks needing review
3 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
Withheld: cost revenue, revenue could not be reconciled with the rest of this filer’s statement.
Difference 15000000 exceeds tolerance 2172400.000. Presentation or filing-vintage differences need review.